Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion description "[Approximately 30-40% of these tumors exhibit clinical features suggestive of endemic Burkitt lymphoma: they are aggressive malignancies that occur in association with Epstein-Barr virus infection, they arise in the setting of immunosuppression, and they carry t(8;14) translocations without detectable rearrangement of the MYC oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion evidence source_evidence_literature NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion SIO_000772 2682665 NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion wasDerivedFrom befree-20140225 NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion wasGeneratedBy ECO_0000203 NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.